GLP-1 Response and Effect in Individuals With Obesity Causing Genetic Mutations
NCT02082496
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Obesity
Interventions
DRUG:
Liraglutide
Sponsor
University of Copenhagen